The mission of the Brown Center for Translational Neuroscience (CTN) is to advance knowledge of the pathogenesis of brain disease and to translate this knowledge to improved clinical outcomes for families affected by brain disease. Brain diseases, such as neurodevelopmental disorders (autism, intellectual disabilities or epilepsy), neuropsychiatric disorders, and neurodegenerative disorders (such as Alzheimer’s disease or amyotrophic lateral sclerosis) affect millions of people worldwide. 

The central goal of the CTN is to harness the power of human genetics and genomics to treat brain diseases. A premise of the CTN is that underlying mechanisms are often shared across seemingly diverse disorders, and advanced molecular methods may be applied across disorders. Therefore, the CTN has a relative emphasis in neurogenetic disorders and molecular therapeutics such as gene therapy.

In order to achieve the CTN mission, the primary objectives will be: 

• Objective 1: To coalesce multidisciplinary teams to bridge between campus-based basic science researchers and hospital-based clinical neuroscience programs.
• Objective 2: To establish a shared infrastructure for translational research.
• Objective 3: To train students and physician-scientists in translational science.
• Objective 4: To enhance community engagement in translational neuroscience through family participation in patient-oriented research and scientific symposiums.

The Center for Translational Neuroscience represents a collaborative endeavor for the Robert J. and Nancy D. Carney Institute for Brain Science and the Division of Biology and Medicine at Brown University.

For any questions related to the CTN's program, scheduling, outreach, or general inquiries, please contact us via email.

Email Us

Join Our Mailing List